JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M002739200 on May 26, 2000

J. Biol. Chem., Vol. 275, Issue 34, 26404-26410, August 25, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/34/26404    most recent
M002739200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abril, A. M.
Right arrow Articles by Hermoso, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abril, A. M.
Right arrow Articles by Hermoso, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Identification of Residues within Two Regions Involved in Self-association of Viral Histone-like Protein p6 from Phage Ø29*

Ana M. AbrilDagger, Margarita Salas§, and José M. Hermoso

From the Centro de Biología Molecular "Severo Ochoa" (Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid), Universidad Autónoma, Canto Blanco, 28049 Madrid, Spain

Received for publication, March 31, 2000, and in revised form, May 23, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Protein p6 of Bacillus subtilis phage Ø29 is involved in the initiation of viral DNA replication and transcription by forming a multimeric nucleoprotein complex with the phage DNA. Based on this, together with its abundance and its capacity to bind to the whole viral genome, it has been proposed to be a viral histone-like protein. Protein p6 is in a monomer-dimer-oligomer equilibrium association. We have identified protein p6 mutants deficient in self-association by testing random mutants obtained by degenerated polymerase chain reaction in an in vivo assay for dimer formation. The mutations were mainly clustered in two regions located at the N terminus, and the central part of the protein. Site-directed single mutants, corresponding to those found in vivo, have been constructed and purified. Mutant p6A44V, located at the central part of the protein, showed an impaired dimer formation ability, and a reduced capacity to bind DNA and to activate the initiation of Ø29 DNA replication. Mutant p6I8T has at least 10-fold reduced self-association capacity, does not bind DNA nor activate Ø29 DNA initiation of replication. C-terminal deletion mutants showed an enhanced dimer formation capacity. The highly acidic tail, removed in these mutants, is proposed to modulate the protein p6 self-association.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

DNA transactions, such as DNA replication and transcription, require higher-order DNA-protein complexes, the assembly of which is sometimes facilitated by proteins with an architectural function. This is the case of the nucleoid-associated proteins, of which the ones most extensively studied are HU, H-NS, IHF, and FIS. They all bind and bend DNA, sharing some common characteristics such as being very abundant, having a small size, and playing a pleiotropic role. The function of these proteins requires formation of dimers or oligomers. Thus, HU is a homodimer in most bacteria, although it is a heterodimer in Escherichia coli (1, 2), IHF is a heterodimeric protein encoded by two genes, himA (3) and hip (4), and FIS is a homodimer (5, 6). On the other hand, H-NS monomers undergo self-association to form tetramers (7). The N-terminal domain of H-NS is involved in oligomerization (8, 9), and the oligomeric structure of H-NS is necessary for recognition of intrinsically curved DNA and bending (10).

Protein p6 of Bacillus subtilis phage Ø29 is required in vivo for viral genome replication (11, 12) and repression of transcription from the early promoter C2 (13). In vitro studies have shown that protein p6 is involved both in replication and transcription; it stimulates the initiation and the transition to elongation steps of Ø29 DNA replication (14, 15), represses the early C2 promoter (16), and regulates the switch between early and late transcription (17). These functions are accomplished by the formation of a nucleoprotein complex in which the DNA adopts a right-handed toroidal conformation, and thus wrapping around a multimeric protein p6 core (18).

The number of copies of protein p6 in B. subtilis cells at late times of Ø29 infection has been calculated to be 6.6 × 105, enough to bind the entire viral progeny DNA (19). This, together with the ability to bind in vitro to the whole Ø29 genome, led us to propose a structural role in compacting and organizing the viral genome (20). The amounts of other histone-like proteins are cell cycle-dependent; thus, for E. coli cells in logarithmic growth, the most abundant ones are FIS and HU, with 1.2 × 104 and 1.5 × 105 copies per cell, respectively, whereas at stationary phase the most abundant is IHF with 1.2 × 104 copies per cell (21). With these amounts, only a minor part of the bacterial genome would be bound by these proteins. Sedimentation equilibrium studies have shown that protein p6 is in a monomer-dimer equilibrium that shifts to higher association states at the millimolar concentrations found in vivo (19). These oligomeric structures have been observed by transmission electron microscopy (22), and their structure, as deduced by image processing, is compatible with that described for the path followed by the DNA in the protein p6·DNA complex (18). Thus, it has been proposed that protein p6 could act as a scaffold organizing the DNA into the appropriate configuration. Protein p6 binding to DNA is highly cooperative1 and extends throughout the whole Ø29 DNA forming multiple complexes of very heterogeneous sizes; the minimal size ranges from ~130 base pairs (bp)2 observed by electron microscopy after psoralen cross-linking, to ~80-90 bp, shown by protection of micrococcal nuclease digestion (20). Thus, multiple protein-DNA and protein-protein interactions are required to stabilize the complex, suggesting that association equilibria among protein p6 oligomers would modulate their interaction with DNA.

In this work we have searched regions involved in protein p6 self-interaction. The characterization of deletion mutants has suggested that the N-terminal region is involved in protein p6 self-association, and the C-terminal acidic region interferes with it. We have obtained a collection of protein p6 random mutants unable to form dimers by using an in vivo self-association assay. The mutations were mainly clustered in two regions, located at the N-terminal and central parts of the protein. This allowed us to design site-directed mutants, which have been tested in vitro. The results obtained indicate that protein p6 dimer formation is drastically reduced by mutation I8T, whereas mutation A44V impairs dimerization and decreases the activation of Ø29 DNA initiation of replication.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Isopropyl beta -D-thiogalactopyranoside (IPTG) and ampicillin were acquired from Sigma. Restriction enzymes (HindIII, EcoRV, BamHI, and DraI), Vent polymerase, and T4-polynucleotide kinase were obtained from New England BioLabs, Taq polymerase from Perkin-Elmer, oligonucleotides from Genset Oligos, dNTP from Amersham Pharmacia Biotech, [alpha -32P]dATP (3000 Ci/mmol) and [gamma -32P]ATP (3000 Ci/mmol) from Amersham International plc. Glutaraldehyde was purchased from Serva.

Construction of Phage lambda  cI Repressor Fusions-- The plasmid pBF21, containing the lambda  cI gene under the control of a tandem lacUV5 promoter-operator region (10), was digested with HindIII and EcoRV to remove the cI gene fragment encoding the oligomerization domain (OD) (Fig. 1). Plasmids pDelta cIp6 and pDelta cIp6m were made by a polymerase chain reaction (PCR) step cloning procedure. Wild-type (wt) gene 6, cloned in plasmid pPR55w6 (23), and mutant gene 6R6A, from plasmid pPR55R6A (23), were obtained by PCR by using primers designed to introduce HindIII and EcoRV restriction sites 5'-GAAAGTGGGAAAGCTTTATGGCAA-3' and 5'-CCTTCTCTTGTGATATCATCATTCAGC-3', respectively. PCRs were carried out with 1 µM oligonucleotides, 0.2 µg of pPR55w6 or pPR55R6A as templates, 100 µM dNTP, and 2 units of Vent polymerase on its reaction buffer. PCR fragments were cloned into digested pBF21, to generate plasmids pDelta cIp6 and pDelta cIp6m, containing chimeric genes encoding for the DNA binding domain of the cI repressor, cI(DBD), fused to those encoding for p6wt protein or to mutant protein p6R6A, respectively (Fig. 1). The wt and mutant gene 6 were sequenced from the plasmids.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic representation of the plasmids used. Plasmid pBF21 encodes the lambda  cI repressor containing both the DNA binding domain (DBD) and the oligomerization domain (OD); plasmid pBF22 encodes only the lambda  cI(DBD), lacking the cI(OD) (Delta cI); plasmid pDelta cIp6 encodes the Delta cI fused to the p6wt protein. Plasmid pDelta cIp6m encodes the Delta cI fused to the p6R6A mutant protein. Mutation R6A abolished the DNA binding ability of protein p6. In all cases these genes are under the control of tandem lacUV5 promoters (lacP). The relative positions of HindIII (H) and EcoRV (EV) restriction sites are indicated. The plasmids contained ampicillin resistance gene (amp).

Random Mutagenesis in Gene 6-- Random mutagenesis of R6A single mutant gene 6 was performed on plasmid pDelta cIp6m. The oligonucleotides used generated HindIII and EcoRV restriction sites (5'-GGCTCCAAGCCAAGCTTTATG-3' and 5'-CGGAATGGACGATATCATCA-3'). To obtain random mutations, PCR was carried out under two different conditions: one had limited dATP (20 µM) and the other had additionally 0.5 mM MnCl2 (24, 25). Thus, the reactions contained 1 µM oligonucleotides; 0.2 µg of plasmid; 1.25 mM MgCl2; 5 units of Taq polymerase; 100 µM each of dCTP, dGTP, and dTTP; and 20 µM dATP, in the absence or in the presence of 0.5 mM MnCl2 in Taq polymerase buffer. The mutated fragments were digested with HindIII and EcoRV and cloned into plasmid pBF21 digested with the same enzymes. E. coli 71-18 lacIq cells (26) were transformed with these constructions and tested for lambda  phage development as described below. The mutated gene 6 was sequenced in those clones showing a lytic phenotype.

lambda Phage Development-- E. coli 71-18 lacIq cells transformed with plasmid pBF21 or the derivatives described above, were grown at 37 °C up to an optical density of 0.6 at 620 nm in LB medium containing ampicillin (100 µg/ml). The production of chimeric proteins was induced by addition of 250 µl of 100 mM IPTG to 0.4 ml of culture. After induction, cells were infected with lambda 146 hypervirulent phage (27), essentially as described (10). After 5-min incubation, 5 ml of LB medium containing ampicillin (100 µg/ml) was added to the infected cultures, which were further incubated at 37 °C. At the indicated times, 0.4-ml aliquots were centrifuged and 150 µl of supernatant was mixed with 30 µl of chloroform. The number of plaques forming units per milliliter in each supernatant was determined using E. coli 71-18 lacIq as the recipient strain.

Site-directed Mutagenesis in Gene 6-- Site-directed mutants of wt gene 6 were constructed by PCR using plasmid pPR55w6 (23) as template. As primers, we have used four oligonucleotides with degenerated positions, to obtain mutations in amino acids 7, 8, 43, and 44 of protein p6 (5'-CGGTTGTCTTTGTGRTTWCTCTCTGC-3'; 5'-GCAGAGAGWAAYCACAAAGACAACCG-3'; 5'-CTCCATTGARCTYGTTCCATTGTC-3'; 5'-GACAATGGAACRAGYTCAATGGAG-3').

Two oligonucleotides 5'-CGACCTGCAGGGATCCGGCC-3' and 5'-CTAATACTAGAAGCTTCTCTTGTG-3' were used to generate BamHI and HindIII restriction sites to clone the fragments containing mutated gene 6 into plasmid pPLc28 (28) under the control of lambda  PL promoter. The lambda  lysogen E. coli K-12Delta H1Delta trp encoding the thermosensitive cI857 repressor (28) was electroporated with the recombinant plasmids to obtain a library of random mutants. The mutations were determined by sequencing the corresponding gene 6 in selected clones from the library.

Purification of Protein p6 Deletion Mutants-- Cultures of E. coli K-12Delta H1Delta trp cells transformed with the recombinant plasmids pMJnDelta 5 and pMJnDelta 13 (29) and pMJcDelta 14 and pMJcDelta 16 (30) were induced for 1 h at 42 °C. After centrifugation, 20 g of cells was ground with alumina and extracted with buffer A (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 7 mM beta -mercaptoethanol, 5% glycerol) with 0.5 M NaCl. Alumina and cell debris were removed by centrifugation. Polyethyleneimine (PEI) was added to the supernatant up to 0.25%, after adjusting absorbance at 260 nm to 120 units/ml, and centrifuged for 10 min at 10,000 × g to remove DNA. The supernatant was made 0.35 M NaCl with buffer A; deletion mutant proteins were recovered in the pellet after centrifugation as above. To eliminate PEI, pellets were resuspended in buffer A containing 0.4 M NaCl, and the proteins were precipitated with ammonium sulfate up to 70% saturation. Pellets containing N-terminal deletion mutants, p6NDelta 5 and p6NDelta 13, were resuspended in buffer A and applied to a DEAE-cellulose column, whereas those containing C-terminal deletion mutants, p6CDelta 14 and p6CDelta 16, were applied to a phosphocellulose column. They were eluted with salt concentrations ranging from 75 to 200 mM NaCl. The mutant proteins were further subjected to heparin-agarose chromatography and eluted at salt concentrations from 50 to 350 mM NaCl. Minor contaminants were eliminated using Centricon-50 from Amicon; after this step the purity of the mutant proteins was estimated to be 95% by SDS-polyacrylamide gel electrophoresis (PAGE) followed by Coomassie Blue staining.

Purification of Protein p6 Site-directed Mutants-- Cultures of E. coli K-12Delta H1Delta trp cells, transformed with plasmids encoding protein p6 site-directed mutants, were induced for 2 h at 42 °C. After centrifugation, 6-8 g of cells was ground with alumina, and the DNA was removed as described above. The mutant proteins were extracted from the PEI pellet by washing with 1 M NaCl buffer A and precipitated with ammonium sulfate to up to 70% saturation. Pellets containing mutant proteins were resuspended in buffer A and applied to a phosphocellulose column, except p6I8T, which was applied to a DEAE-cellulose column. The different protein p6 mutants were eluted with buffer A containing NaCl concentrations from 75 to 200 mM. Minor contaminants were eliminated by 15-30% glycerol gradient centrifugation. After this step all protein p6 single mutants were more than 90% homogeneous as estimated by SDS-PAGE followed by Coomassie Blue staining.

Initiation of DNA Replication Assay-- The reaction mixture contained (in 25 µl) 50 mM Tris-HCl, pH 7.5; 10 mM MgCl2; 20 mM ammonium sulfate; 1 mM dithiothreitol; 10% glycerol; 0.25 µM [alpha -32P]dATP; 0.3 µg of phage Ø29 terminal protein-DNA complex, purified as described (31); 20 ng of terminal protein; 20 ng of Ø29 DNA polymerase; and the indicated amounts of either protein p6wt or protein p6 mutants. After incubation for 15 min at 15 °C, the reaction was stopped by adding up to 10 mM EDTA and 0.1% SDS. The samples were filtered through Sephadex G-50 spin columns in the presence of 0.1% SDS. The initiation complex formed was analyzed by SDS-PAGE as described (31). Quantification was performed by using a Fuji BAS-1500 image analyzer.

Cross-linking with Glutaraldehyde-- Glutaraldehyde cross-linking was carried out essentially as described (32). Either wt or mutant p6 proteins, 5 µM each, were incubated at room temperature in 20 mM triethanolamine, pH 8.0, 50 mM NaCl, and 300 µM glutaraldehyde. After 45-min incubation, the reaction was stopped by adding Tris-HCl, pH 7.5, up to 150 mM. Samples were analyzed by SDS-Tricine-PAGE (33).

Sedimentation Equilibrium Analysis-- The experiments were performed in a Beckman Optima XL-A analytical ultracentrifuge equipped with absorbance optics, using an An60Ti rotor. Protein p6 was equilibrated in 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, and 50 mM NaCl. Protein p6 (100 µl of 100 µM) was centrifuged at 25,000 rpm, and absorbance scans at 280 nm were taken at sedimentation equilibrium. The equilibrium temperature was 4 °C. High speed sedimentation (42,000 rpm) was conducted afterward for baseline correction.

Whole cell apparent weight average molecular weights (Mw,a) were determined by fitting a sedimentation equilibrium model for a single sedimenting solute to individual datasets with the program EQASSOC (supplied by Beckman, Ref. 34). The partial specific volume of protein p6 was 0.728 ml/g, calculated from the amino acid composition of the protein deduced from the gene 6 sequence (35).

DNase I Footprinting-- DNase I footprinting was carried out essentially as described (36). The indicated amounts of either wt or mutant p6 proteins were incubated with 2 ng of Ø29 DNA left terminal fragment, 259 bp long. The DNA fragment was obtained by PCR in a reaction containing 0.2 µg of Ø29 DNA as template, 1 µM oligonucleotides 5'-GCGCTTTAAAGTAAGCCCCCACCCTC-3' and 5'-GCCCACATACTTTGTTGATTGG-3', 100 µM dNTP, and 2 units of Vent polymerase in its reaction buffer. The last oligonucleotide was previously 5'-labeled with [gamma -32P]ATP using T4 polynucleotide kinase to obtain the Ø29 DNA terminal fragment internally labeled. The PCR product was digested with DraI to restore the Ø29 DNA terminal end. DNase I digestion was carried out for 5 min at 15 °C in 25 µl of a solution containing 10 mM MgCl2. The reaction was stopped by addition of EDTA, pH 8.0, up to 20 mM final concentration. DNA was precipitated with ethanol in the presence of RNA carrier (0.25 mg/ml) and then subjected to denaturing electrophoresis in 6% (w/v) acrylamide gel.

Circular Dichroism-- Circular dichroism spectra were recorded using a Jasco J-720 spectropolarimeter using a 0.2-cm path length cuvette. Proteins were used at room temperature at a concentration of 0.13 g/l in 10 mM Tris-HCl, pH 7.5. The final spectrum in each case is the mean of 10 measurements with a step size of 0.2 nm recorded from 260 to 200 nm. Data were base line-corrected by substraction of that of the Tris buffer.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Self-association of Protein p6 Deletion Mutants-- It has been reported that N-terminal deletion mutants of protein p6 lacking 5 or 13 amino acids (p6NDelta 5 and p6NDelta 13, respectively) were not able to interact with a Ø29 DNA terminal fragment as detected by DNase I footprinting (29). Because DNA binding is highly cooperative1 and requires the formation of large oligomers, the lack of DNA binding could be due to a deficiency in protein p6 self-association; therefore, we tested by glutaraldehyde cross-linking the capability of both deletion mutants to self-associate. Fig. 2 shows that dimer formation was highly impaired in the p6NDelta 5 mutant, being about 10% that of the p6wt protein. In addition, dimers were not detected with the p6NDelta 13 mutant (not shown). On the other hand, a 14-amino acid C-terminal deletion mutant of protein p6 (p6CDelta 14) bound DNA 2-fold better than the p6wt protein (30). Two C-terminal deletion mutants of 14 and 16 amino acids (p6CDelta 14 and p6CDelta 16, respectively) were tested for dimer formation by glutaraldehyde cross-linking. As Fig. 2 shows, the ability of dimer formation in the p6CDelta 16 mutant protein was about 2-fold that of the p6wt protein; a similar result was obtained with the mutant protein p6CDelta 14 (not shown). Therefore, the observed DNA binding properties of p6NDelta 5, p6NDelta 13, p6CDelta 14, and p6CDelta 16 mutants could be explained by their self-association capacities. These results indicate that the N-terminal region of protein p6 is required for glutaraldehyde cross-linking, suggesting that this region is involved in dimer formation; however, glutaraldehyde cross-linking is favored when the C-terminal region is removed, suggesting that this region impairs dimer formation.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 2.   Dimer formation of protein p6wt and deletion mutants. wt protein p6, the 5-amino acid N-terminal deletion mutant p6NDelta 5, and the 16-amino acid C-terminal deletion mutant p6CDelta 16 were cross-linked with glutaraldehyde as described under "Experimental Procedures" and run in SDS-Tricine-PAGE along with untreated samples. The mobilities of molecular mass standards are indicated.

Self-interaction of Protein p6 in Vivo-- To further investigate the protein p6 regions involved in self-association, we carried out an in vivo assay in which we used the region encoding the N-terminal domain of lambda  cI repressor as a reporter gene for dimerization (10). Phage lambda  cI repressor is a two-domain protein that binds DNA as a dimer; the N-terminal part is the DNA binding domain, cI(DBD), whereas the C-terminal one is the oligomerization domain, cI(OD), which is required for an efficient binding to the operator. Thus, E. coli cells expressing only cI(DBD) (Delta cI) were sensitive to hypervirulent phage lambda 146 infection, whereas those with intact cI were immune. Replacement of the cI(OD) by another protein provides a self-interaction assay for that protein.

We have used the plasmid pBF21 (10), expressing the lambda  phage cI repressor under the control of the lac promoter, to construct pDelta cIp6 plasmid encoding a fusion protein containing the Delta cI and the protein p6wt (Fig. 1). The dimerization capacity of protein p6 was assayed by determining the development of infecting lambda 146 phage in E. coli cells harboring the pDelta cIp6 plasmid upon induction with IPTG. Cells expressing the Delta cIp6 fusion protein were not immune to lambda 146 infection (Fig. 3), behaving as the control cells expressing Delta cI. This result was unexpected, because protein p6 self-interacts in vitro. The expression of Delta cIp6 fusion protein was confirmed by Western blot analysis with protein p6 antiserum (not shown). An explanation for the lytic phenotype could be that the non sequence-specific DNA binding ability of protein p6 (37) prevented the binding of the Delta cI to the operators. To avoid this, plasmid pDelta cIp6m (see Fig. 1) was constructed, expressing a fusion containing the Delta cI and the protein p6 mutant defective in DNA binding p6R6A (38). Cells harboring the plasmid pDelta cIp6m showed, upon induction, a time course development of lambda 146 phage similar to that of the control cells expressing intact lambda  cI repressor. In these cases, the number of pfu/ml was about 104-fold lower than that obtained in cells expressing Delta cI (Fig. 3). Therefore, we can conclude that the mutant protein p6R6A functionally replaces the cI(OD) allowing dimerization of the Delta cI. This strongly suggests that protein p6 self-associates in vivo.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   In vivo dimerization assay for protein p6. Phage lambda 146 development, represented as the number of pfu/ml produced at the indicated times after infection, in cells expressing lambda  cI repressor wt (cI), lambda  cI(DBD) (Delta cI), Delta cI-p6wt fusion protein (Delta cIp6), and Delta cI-p6R6A mutant fusion protein (Delta cIp6m).

Random Mutagenesis of Gene 6 and in Vivo Selection of Protein p6 Mutants Defective in Self-interaction-- The in vivo assay described above sets up the basis to select mutants in self-association. Because Delta cIp6m fusion protein confers immunity to lambda 146 infection, random mutagenesis was performed on mutant gene 6R6A contained in plasmid pDelta cIp6m. The PCR products were cloned as above, under the control of the lac promoter, in-frame to the cI(DBD). Therefore, chimeric proteins consisting of Delta cI and random mutants of protein p6R6A were expressed. Individual colonies were tested for lambda  phage development as above, and clones showing a lytic phenotype were selected as candidates defective in protein p6 self-interaction. From 200 individual clones, 35 showed a lytic phenotype. Fig. 4 shows the development of lambda 146 phage in selected lytic clones, which was about 104-fold higher than that of cells expressing Delta cIp6m. The expression of the fusion proteins was assessed by Western immunoblotting analysis using antiserum against protein p6 (not shown).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   In vivo dimerization assay for random mutants of protein p6R6A. Time-course development (pfu/ml) of lambda 146 phage after infection of E. coli 71-18 lacIq cells harboring plasmids expressing Delta cIp6m8, Delta cIp6m22, Delta cIp6m23, Delta cIp6m41, or Delta cIp6m94 fusion proteins. Cells expressing the Delta cIp6m fusion protein were used as a control.

The entire nucleotide sequence of the mutated gene 6 was determined from the 35 lytic clones. Four of them had a premature stop codon. Most of the mutants had more than three amino acid changes, and only five carried double or triple mutations as shown in Fig. 5. Amino acid sequence comparison with the p6R6A protein (p6m) showed that the mutations were mainly clustered in two regions: N-terminal, around position 8 (region I, Fig. 5), like those in p6m8 and p6m22 mutant proteins, and a central region around position 44 (region II, Fig. 5), like p6m23 and p6m41 mutant proteins. Mutant protein p6m94 carried a single mutation in each region.


View larger version (8K):
[in this window]
[in a new window]
 
Fig. 5.   Amino acid sequence of random mutant p6 proteins. Amino acid sequence of protein p6R6A mutant (p6m) and the in vivo selected mutants shown in Fig. 4. Only differences with p6R6A protein are indicated. I and II indicate the clusters of point mutations found in the in vivo selected random mutants. Basic and acidic regions of the proteins are pointed out.

Residues Involved in Self-association of Protein p6 in Vitro-- The non-random distribution of in vivo selected mutants strongly suggested the involvement of regions I and II in protein p6 self-interaction. To assess directly the involvement of individual residues in protein-protein interaction, we designed site-directed mutations on positions 7, 8, 43, and 44, where wt residues were replaced by those found in mutants selected in vivo (Fig. 5), namely E7V, I8T, Q43R, and A44V. The site-directed mutagenesis was performed by PCR on plasmid pPR55w6, encoding wt gene 6 (23). The mutated genes were cloned into an expression vector under the control of the bacteriophage lambda  PL promoter. Mutants were overproduced and purified up to at least 90% homogeneity. Protein p6 mutants were tested for activation of initiation of phage Ø29 DNA replication in an in vitro assay with purified proteins (14). Fig. 6 shows the results obtained with the mutant proteins p6E7V, p6I8T, p6Q43R, and p6A44V. Although the mutants p6E7V and p6Q43R showed an activation similar to that of the p6wt protein, the p6A44V mutant protein exhibited about a 6-fold reduced capacity to activate the initiation reaction. No activation was detected by the p6I8T mutant. The deficiency observed in the activation of the initiation reaction in p6A44V and p6I8T mutant proteins could be due to an impaired self-association and/or DNA binding. Because we have selected these mutants in an in vivo self-association assay, we first studied the dimerization properties of the protein p6 mutants. The effect of the p6A44V and p6I8T mutations in self-interaction was tested, as a first approach, by glutaraldehyde cross-linking. The amount of dimers formed by the p6A44V and p6I8T mutant proteins was 50% and 7%, respectively, of that found in the p6wt protein (Fig. 7).


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 6.   Activation of initiation of Ø29 DNA replication by wt protein p6 and site-directed mutants. Formation of the initiation complex (TP-dAMP) in the absence or in the presence of the indicated amount of wt protein p6 or site-directed mutants p6E7V, p6I8T, p6Q43R, or p6A44V.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 7.   Dimer formation of protein p6wt and site-directed mutants. Glutaraldehyde cross-linking of protein p6wt and single mutants p6A44V and p6I8T. Proteins were cross-linked as described under "Experimental Procedures" and run in SDS-Tricine-PAGE, along with untreated samples. The mobilities of molecular mass standards are indicated.

These results prompted us to further study the self-interaction capability of the protein p6 mutants by analytical ultracentrifugation. Sedimentation equilibrium studies had shown that protein p6, in the 1-100 µM range, is in a monomer-dimer equilibrium with a dimerization constant (K2) of 2 × 105 M-1 that shifts to higher association states at higher protein concentration (19). Fig. 8 shows that, at 100 µM and 4 °C, the Mw,a) of protein p6wt was 25,400, whereas those of p6A44V and p6I8T mutant proteins were 20,600 and 15,500, respectively, the latter being close to the theoretical value for the wt protein p6 monomer (11,900). Assuming that mutant proteins have the same self-association behavior as p6wt (19), the dimerization constant of p6A44V is slightly lower than that of the p6wt3; however, the K2 of p6I8T is, at least, 10-fold lower than that of the p6wt protein.3 Therefore, we can conclude that A44V mutation slightly affects protein dimerization, which is almost abolished by the mutation I8T.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 8.   Sedimentation equilibrium analysis of protein p6wt and site-directed mutants. Sedimentation equilibrium profile of 100 µM protein p6wt (open circle ), p6A44V (), and p6I8T (triangle ) taken at 25,000 rpm and 4 °C as described under "Experimental Procedures." The symbols represent the experimental data, and the solid lines show the best fit functions for a single solute, at sedimentation equilibrium. The Mw,a for each protein is indicated.

Protein p6 forms a nucleoprotein complex with phage Ø29 DNA terminal fragments, in which the DNA wraps around a multimeric protein core (39). The formation of the complex can be detected by a characteristic DNase I footprint pattern, in which strong hypersensitivities, with a periodicity of 24 bp, are located in between protected regions (36). As shown in Fig. 9, protein p6A44V required a 2.5-fold higher protein amount (0.5 µg) than protein p6wt (0.2 µg) to form the complex; this may reflect the reduced capacity to form dimers of p6A44V mutant. In addition, we can observe that the digestion pattern formed with p6A44V is slightly different than that observed with p6wt. As it could be expected from the previous results, p6I8T mutant protein failed to bind DNA even at a 20-fold higher protein concentration than that of the p6wt (Fig. 9).


View larger version (60K):
[in this window]
[in a new window]
 
Fig. 9.   DNA binding of protein p6wt and site-directed mutants. The 259-bp left terminal fragment of Ø29 DNA was used to perform DNase I footprinting of p6wt and site-directed mutants p6A44V and p6I8T. The protein amount used as well as the nucleotide positions from the left Ø29 genome end are indicated.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Protein p6 of B. subtilis phage Ø29 binds DNA forming a multimeric nucleoprotein complex (39) that is required for activation of Ø29 DNA initiation of replication (37, 38), repression of transcription from early C2 promoter (13, 16), and regulation of viral switch between early and late transcription (17). Protein p6 in solution forms elongated oligomers from preformed dimers, at the in vivo estimated protein concentration (19). Oligomeric structures have been proposed to provide the scaffold on which the DNA folds into the appropriate configuration. Protein p6 binding to DNA requires multiple protein-DNA and protein-protein interactions. Thus, failure to bind DNA of N-terminal deletion mutants of 5 or 13 amino acids in protein p6 (29), can be explained by their impaired or lost capacity, respectively, in dimer formation.

We have looked for other regions involved in protein p6 self-association by using an in vivo system based on the immunity of cells expressing lambda  cI repressor to lambda  phage infection. If the lambda  cI(OD) is removed, immunity is lost and the infecting phage can develop lytic cycle. Thus, replacement of the cI(OD) by other protein provides a self-interaction test for this protein. When Delta cI was fused to the gene encoding p6R6A mutant protein, immunity was achieved, suggesting that the protein self-interacts in vivo. Thus, random mutants of protein p6R6A, obtained by degenerated PCR, were tested for self-association. Although the proteins contained multiple mutations, they were not randomly arranged, but mainly clustered in two regions located at the N-terminal and the central region of protein p6 (regions I and II in Fig. 5). Therefore, single site-directed mutants of protein p6wt corresponding to some of those found in vivo were constructed and assayed in vitro. Taking into account that the in vivo selected mutant proteins p6m23 and p6m41 (Fig. 5) share the Q43R mutation, we would expect an involvement of Gln43 in protein p6 self-interaction. However, this was not confirmed by in vitro experiments with the corresponding site-directed mutant. The mutant protein p6Q43R did not show any significant difference with the wt protein in the activation of Ø29 DNA initiation of replication or glutaraldehyde cross-linking. A possible explanation for this result could be that the in vivo assay is more restrictive. In addition, the single mutation may not be enough to show an impaired dimerization, and additional changes might be required, like those found in the in vivo selected mutants.

The involvement of region II in dimer formation is shown by p6A44V mutant protein, which has a slightly reduced capacity to form dimers. In agreement with this, DNase I footprinting (Fig. 9) shows that p6A44V has a DNA binding affinity lower than that of the p6wt protein and an impaired activation of Ø29 DNA initiation of replication.

The involvement in dimer formation of region I (see Fig. 5) was expected from the results obtained with protein p6 N-terminal deletion mutants. The p6I8T mutant protein failed to activate the Ø29 DNA initiation of replication, DNA binding was not detected, and dimer formation was reduced at least 10-fold. Mutant p6 proteins are folded, as shown in Fig. 10, where the circular dichroism spectra of the wt and mutant p6 proteins do not show significant differences in their secondary structure. Altogether, these results suggest that Ile8 is involved in the self-interaction of protein p6.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 10.   Circular dichroism spectra of the wild-type and single mutant proteins. The spectrum of the p6wt protein (), p6A44V (open circle ), and p6I8T () after base line correction.

It has been reported that a C-terminal, 14-amino acid truncated p6 protein has a DNA binding activity 2-fold higher than that of the p6wt protein (30). We have now shown that this truncated protein has increased its capacity to form dimers. Protein p6 has a very acidic C terminus, where 10 out of 19 residues are either Asp or Glu (see Fig. 5). Therefore, it seems likely that the C-terminal acidic region modulates protein p6 self-association, interacting with a basic region. There is a cluster of basic residues overlapping region II (see Fig. 5), although interaction with region I, which also contains basic residues, cannot be ruled out. This interaction could contribute to the dynamic nature of the protein p6 binding to DNA (20).

In summary, we have found two regions involved in vivo in self-association of phage Ø29 protein p6, the N-terminal and a central region. Site-directed mutation A44V, located at the central region, impairs the protein p6 self-association. The N-terminal mutation I8T has a more drastic effect and completely abolished dimer formation.

    ACKNOWLEDGEMENTS

We are very grateful to Drs. R. Spurio and C. O. Gualerzi for kindly providing us plasmids pBF21 and pBF22, lambda 146 phage, and E. coli strain 71-18 lacIq; J. Fernández and Dr. G. Rivas for their help with the analytical ultracentrifugation experiments; Dr. R. Giraldo for help in the circular dichroism experiments; J. M. Lázaro and L. Villar for the purification of wt and site-directed p6 mutant proteins; and Dr. A. Bravo for helpful discussions.

    FOOTNOTES

* This work was supported by Research Grant 5R01 GM27242-20 from the National Institutes of Health, by Grant PB98-0645 from Dirección General de Investigación Científica y Técnica, by Grant ERBFMX CT97 0125 from the European Union, and by an institutional grant from Fundación Ramón Areces.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of a predoctoral fellowship from Comunidad Autónoma de Madrid.

§ To whom correspondence should be addressed: Tel.: 34-91-3978435; Fax: 34-91-3974799; E-mail: msalas@cbm.uam.es.

Published, JBC Papers in Press, May 26, 2000, DOI 10.1074/jbc.M002739200

1 A. M. Abril, unpublished results.

3 G. Rivas, personal communication.

    ABBREVIATIONS

The abbreviations used are: bp, base pairs(s); OD, oligomerization domain; DBD, DNA binding domain; wt, wild-type; pfu, plaque-forming units; PEI, polyethyleneimine; Mw, a, apparent weight-average molecular weight; IPTG, isopropyl beta -D-thiogalactopyranoside; PAGE, polyacrylamide gel electrophoresis.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Rouvière-Yaniv, J., and Kjeldgaard, N. O. (1979) FEBS Lett. 106, 297-300
2. Claret, L., and Rouvière-Yaniv, J. (1997) J. Mol. Biol. 273, 93-104
3. Miller, H. I. (1984) Cold Spring Harbor Symp. Quant. Biol. 43, 1121-1126
4. Flamm, E. L., and Weisberg, R. A. (1985) J. Mol. Biol. 183, 117-128
5. Johnson, R. C., Ball, C. A., Pfeffer, D., and Simon, M. I. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 3484-3488
6. Koch, C., Vandekerckhove, J., and Kahmann, R. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 4237-4241
7. Ceschini, S., Lupidi, G., Coletta, M., Pon, C. L., Fioretti, E., and Angeletti, M. (2000) J. Biol. Chem. 275, 729-734
8. Ueguchi, C., Seto, C., Suzuki, T., and Mizuno, T. (1997) J. Mol. Biol. 274, 145-151
9. Williams, R. M., Rimsky, S., and Buc, H. (1996) J. Bacteriol. 178, 4335-4343
10. Spurio, R., Falconi, M., Brandi, A., Pon, C. L., and Gualerzi, C. O. (1997) EMBO J. 16, 1795-1805
11. Talavera, A., Salas, M., and Viñuela, E. (1972) Eur. J. Biochem. 31, 367-371
12. Carrascosa, J. L., Camacho, A., Moreno, F., Jiménez, F., Mellado, R. P., Viñuela, E., and Salas, M. (1976) Eur. J. Biochem. 66, 229-241
13. Whiteley, H. R., Ramey, W. D., Spiegelman, G. B., and Holder, R. D. (1986) Virology 155, 392-401
14. Pastrana, R., Lázaro, J. M., Blanco, L., García, J. A., Méndez, E., and Salas, M. (1985) Nucleic Acids Res. 13, 3083-3100
15. Blanco, L., Gutiérrez, J., Lázaro, J. M., Bernad, A., and Salas, M. (1986) Nucleic Acids Res. 14, 4923-4937
16. Barthelemy, I., Mellado, R. P., and Salas, M. (1989) J. Virol. 63, 460-462
17. Elías-Arnanz, M., and Salas, M. (1999) Genes Dev. 13, 2502-2513
18. Serrano, M., Gutiérrez, C., Salas, M., and Hermoso, J. M. (1993) J. Mol. Biol. 230, 248-259
19. Abril, A. M., Salas, M., Andreu, J. M., Hermoso, J. M., and Rivas, G. (1997) Biochemistry 36, 11901-11908
20. Gutiérrez, C., Freire, R., Salas, M., and Hermoso, J. M. (1994) EMBO J. 13, 269-276
21. Azam, T. A., Iwata, A., Nishimura, A., Ueda, S., and Ishihama, A. (1999) J. Bacteriol. 181, 6361-6370
22. Abril, A. M., Marco, S., Carrascosa, J. L., Salas, M., and Hermoso, J. M. (1999) J. Mol. Biol. 292, 581-588
23. Bravo, A., Hermoso, J. M., and Salas, M. (1994) Mol. Gen. Genet. 245, 529-536
24. Arcangioli, B., Ghazvini, M., and Ribes, V. (1994) Nucleic Acids Res. 22, 2930-2937
25. Leung, D. W., Chen, E., and Goeddel, D. V. (1989) Technique 1, 11-15
26. Yanisch-Perron, C., Vieira, J., and Messing, J. (1985) Gene 33, 103-119
27. Bailone, A., and Devoret, R. (1978) Virology 84, 547-550
28. Remaut, E., Stanssens, P., and Fiers, W. (1981) Gene 15, 81-93
29. Otero, M. J., Lázaro, J. M., and Salas, M. (1990) Gene 95, 25-30
30. Otero, M. J., and Salas, M. (1989) Nucleic Acids Res. 17, 4567-4577
31. Peñalva, M. A., and Salas, M. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 5522-5526
32. Balzer, D., Ziegelin, G., Pansegrau, W., Kruft, V., and Lanka, E. (1992) Nucleic Acids Res. 20, 1851-1858
33. Schagger, H., and Jagow, G. (1987) Anal. Biochem. 166, 368-379
34. Minton, A. P. (1994) in Modern Analytical Ultracentrifugation (Shuster, T. M. , and Laue, T. M., eds) , pp. 81-93, Birkhauser, Boston, MA
35. Murray, C. L., and Rabinowitz, J. C. (1982) J. Biol. Chem. 257, 1053-1062
36. Prieto, I., Serrano, M., Lázaro, J. M., Salas, M., and Hermoso, J. M. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 314-318
37. Serrano, M., Gutiérrez, J., Prieto, I., Hermoso, J. M., and Salas, M. (1989) EMBO J. 8, 1879-1885
38. Freire, R., Salas, M., and Hermoso, J. M. (1994) EMBO J. 13, 4353-4360
39. Serrano, M., Salas, M., and Hermoso, J. M. (1990) Science 248, 1012-1016


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Microbiol. Mol. Biol. Rev.Home page
W. J. J. Meijer, J. A. Horcajadas, and M. Salas
{phi}29 Family of Phages
Microbiol. Mol. Biol. Rev., June 1, 2001; 65(2): 261 - 287.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/34/26404    most recent
M002739200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abril, A. M.
Right arrow Articles by Hermoso, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abril, A. M.
Right arrow Articles by Hermoso, J. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals